SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
Vikas Lifecare has already paid Rs. 25 million to the Advik bankers till date and the remaining amount shall also be paid within July 2021, making Advik a debt free company
The company has already embarked upon significant expansion in Turkey
Price adjustments will vary depending on geographic region, products offered, and market(s) served
The partial decision, issued on June 22, ordered Edison to compensate Solvay for losses and damages incurred up to the end of 2016
The plant will have capabilities to manufacture a broad slate of chemicals for stimulation, production, midstream, and downstream engineered treatment programs
The price band of the offer has been fixed at Rs. 1,073 - 1,083 per equity share and bids can be made for a minimum of 13 equity shares
Conceptualized in 2017, UrbanKisaan operates several suburban greenhouses and vertical indoor farms in Hyderabad and Bangalore
ICICI Direct expects its chemical universe to register topline growth of 26.1% YoY while bottomline is expected to grow 67.1% YoY in last quarter.
Company has selected three new growth engines that will be in accordance with ESG, while maximizing the growth potential of existing businesses
The new plant, representing an investment of 4 million euros, is expected to be operational by mid-2022
The multi-year partnership aims to discover new enzymes that will help to transform the sustainability and performance of cleaning and laundry products
As of Q4 FY21, 60% of Epichlorohydrin project, 40% of CPVC project and 40% of Caustic Soda project was completed
New set-up will help the company to better serve its local customers and support its growth plans for the Middle East and Africa
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
Company initially will produce carbon fiber materials for sports and outdoor activities
The transaction is expected to close in the first half of 2022
The sale of allnex to PTTGC International (Netherlands) B.V. is expected to close in Q4 2021, subject to regulatory approvals
Company's EBITDA is expected to be between EUR 2,700 million and EUR 3,100 million versus the previous forecast projected EBITDA between EUR 2,200 million and EUR 2,700 million
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
